Samuel Merryn Jones

This paper develops engineered yeast biofilms that deliver PET-degrading enzymes directly to substrates, demonstrating a proof-of-principle for biofilm-based bioremediation without enzyme purification.

This paper describes the processing pipeline and findings from SARS-CoV-2 genomics data collected from ambulatory patients treated with neutralizing monoclonal antibodies, showing variant distribution and mutations associated with antibody escape.